Role of Probiotics in health improvement, infection control and disease treatment and management

Saudi Pharmaceutical Journal

Volumn 23, Issue 2, 2015, Pages 107-114

  Amara, A A ^a,b   Shibl, A ^b  

^a City of Scientific Research and Technological Applications   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Disease management; Health; Infections; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; NISIN; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ASPERGILLUS NIGER; ASPERGILLUS ORYZAE; BIFIDOBACTERIUM; CANDIDA; CARDIOVASCULAR DISEASE; COLON CANCER; CROHN DISEASE; ECZEMA; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; FOOD ALLERGY; FOOD INDUSTRY; GASTROENTERITIS; HELICOBACTER INFECTION; HUMAN; HYPERCHOLESTEROLEMIA; INFECTION CONTROL; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LEUCONOSTOC MESENTEROIDES; PEDIOCOCCUS; PROPIONIBACTERIUM; REVIEW; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; TRAVELLER DIARRHEA; ULCERATIVE COLITIS; WORLD HEALTH ORGANIZATION;

EID: 84938974327     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2013.07.001     Document Type: Review

References (68)

1. Abdin A.A., Saeid E.M. An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without "olsalazine". J. Crohns. Colitis. 2008, 2:296-303.
2. Adam B., Liebregts T., Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Z. Gastroenterol. 2006, 44:267-269.
3. Aiba Y., Suzuki N., Kabir A.M., Takagi A., Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a Probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 1998, 93:2097-2101.
4. Amara A. Toward Healthy Genes 2012, Schüling Verlage, Germany. A. Amara (Ed.).
5. Amara A.A. The inevitability of balanced lives: genes-foods - action-interactions. IIOBJ 2013, 4(2):1-27.
6. Anukam K.C., Hayes K., Summers K., Reid G. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study. Adv. Urol. 2009, 680363.
7. Bandyopadhyay P., Das Mohapatra P.K. Effect of a Probiotic bacterium Bacillus circulans PB7 in the formulated diets: on growth, nutritional quality and immunity of Catla catla (Ham.). Fish Physiol. Biochem. 2009, 35:467-478.
8. Bazzoli F., Zagari R.M., Fossi S. In vivo Helicobacter pyloriclearance failure with Lactobacillus acidophilus. Gastroenterology 1992, 102:A38.
9. Benchimol E.I., Mack D.R. Probiotics in relapsing and chronic diarrhea. J. Pediatr. Hematol. Oncol. 2004, 26:515-517.
10. Bennett R.G., Gorbach S.L., Goldin B.R., Chang T., Laughon B.E., Greenough W.B., Bartlett J.G. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutr. Today 1996, 31:35S-39S.
11. Botes M., Loos B., van Reenen C.A., Dicks L.M. Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments. Arch. Microbiol. 2008, 190:573-584.
12. Boudeau J., Glasser A.L., Julien S., Colombel J.F., Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment. Pharmacol. Ther. 2003, 18:45-56.
13. Bourdichon F., Casaregola S., Farrokh C., Frisvad J.C., Gerds M.L., Hammesf W.P., Harnett J., Huys G., Laulund S., Ouwehand A., Powell I.B., Prajapati J.B., Seto Y., Schure E.T., Van Boven A., Vankerckhoven V., Zgoda A., Tuijtelaars S., Hansen E.B. Food fermentations: microorganisms with technological beneficial use. Int. J. Food Microbiol. 2012, 154:87-97.
14. Brenner D.M., Chey W.D. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome. Rev. Gastroenterol. Disord. 2009, 9:7-15.
15. Cammarota M., De Rosa M., Stellavato A., Lamberti M., Marzaioli I., Giuliano M. In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: emphasis on innate immunity. Int. J. Food Microbiol. 2009, 135:90-98.
16. del Miraglia G.M., De Luca M.G. The role of Probiotics in the clinical management of food allergy and atopic dermatitis. J. Clin. Gastroenterol. 2004, 38:S84-S85.
17. DeSimone C. The adjuvant effect of yogurt on gamma interferon by Con-A stimulated human lymphocytes. Nutr. Rep. Int. 1986, 33:419-433.
18. Enck P., Zimmermann K., Menke G., Klosterhalfen S. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z. Gastroenterol. 2009, 47:209-214.
19. Fernandes C.F., Shahani K.M., Amer M.A. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiol. Rev. 1987, 46:343-356.
20. Filippo C., Filippo C., Di Caro S., Santarelli L., Armuzzi A., Gasbarrini G., Gasbarrini A. Helicobacter pylori treatment: a role for Probiotics. Dig. Dis. 2001, 19:144-147.
21. Fioramonti J., Theodorou V., Bueno L. Probiotics: what are they? What are their effects on gut physiology?. Best Pract. Res. Clin. Gastroenterol. 2003, 17:711-724.
22. Food and Agriculture Organization/World Health Organization (FAO/WHO), 2001. Health and nutritional properties of Probiotics in food including powder milk with live lactic acid bacteria, Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live lactic acid bacteria, Córdoba, Argentina. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
23. Fukao M., Tomita H., Yakabe T., Nomura T., Ike Y., Yajima N. Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290. J. Food Prot. 2009, 72:1923-1929.
24. Gest H. The discovery of microorganisms by Robert Hooke and Antoni van Leeuwenhoek, Fellows of The Royal Society. Notes Records R. Soc. Lond. 2004, 58:187-201.
25. Giralt J., Regadera J.P., Verges R., Romero J., de la Fuente I., Biete A., Villoria J., Cobo J.M., Guarner F. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int. J. Radiat. Oncol. Biol. Phys. 2008, 71:1213-1219.
26. Gismondo M.R., Drago L., Lombardi A. Review of Probiotics available to modify gastrointestinal flora. Int. J. Antimicrob. Agents 1999, 12:287-292.
27. Hawrelak J. Probiotics: choosing the right one for your needs. J. Aust. Traditional-Med. Soc. 2003, 9(2):67-75.
28. Hilton E., Kolakawaki P., Singer C., Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J. Travel Med. 1977, 4:41-43.
29. Hlivak P., Odraska J., Ferencik M., Ebringer L., Jahnova E., Mikes Z. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl. Lek. Listy 2005, 106:67-72.
30. Hosono A. Fermented milk in the orient. Functions of Fermented Milk: Challenges for the Health Sciences 1992, 61-78. Elsevier Applied Science, London, UK. Y. Naga sawa, A. Hosono (Eds.).
31. Huurre A., Laitinen K., Rautava S., Korkeamaki M., Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin. Exp. Allergy 2008, 38:1342-1348.
32. Iarovenko I.I., Golofeevskii V., Sitkin S.I. The new possibilities for improving peptic ulcer therapy with the use of probiotic drugs. Voen. Med. Zh. 2007, 328:17-22.
33. Imaoka A., Shima T., Kato K., Mizuno S., Uehara T., Matsumoto S., Setoyama H., Hara T., Umesaki Y. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J. Gastroenterol. 2008, 14:2511-2516.
34. Isolauri E. Dietary modification of atopic disease: Use of Probiotics in the prevention of atopic dermatitis. Curr. Allergy Asthma Rep. 2004, 4:270-275.
35. Kailasapathy K., Chin J. Survival and therapeutic potential of Probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 2000, 78:80-88.
36. Kennedy R.J., Hoper M., Deodhar K., Kirk S.J., Gardiner K.R. Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand. J. Gastroenterol. 2000, 35:1266-1271.
37. Kiatpapan P., Yamashita M., Kawaraichi N., Yasuda T., Murooka Y. Heterologous expression of a gene encoding cholesterol oxidase in probiotic strains of Lactobacillus plantarum and Propionibacterium freudenreichii under the control of native promoters. J. Biosci. Bioeng. 2001, 92:459-465.
38. Levy J. The effects of antibiotic use on gastrointestinal function. Am. J. Gastroenterol. 2000, 95:S8-S10.
39. Lilly D.M., Stillwell R.H. Probiotics: Growth-promoting factors produced by microorganisms. Science 1965, 147:747-748.
40. Lodinova-Zadnikova R., Cukrowska B., Tlaskalova-Hogenova H. Oral administration of Probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int. Arch. Allergy Immunol. 2003, 131:209-211.
41. MacFarlane G.T., Cummings J.H. Probiotics, infection and immunity. Curr. Opin. Infect. Dis. 2002, 15:501-506.
42. Marteau P.R., de Vrese M., Cellier C.J., Schrezenmeir J. Protection from gastrointestinal diseases with the use of Probiotics. Am. J. Clin. Nutr. (Suppl.) 2001, 73:430-436.
43. Martinez R.C., Franceschini S.A., Patta M.C., Quintana S.M., Candido R.C., Ferreira J.C., De Martinis E.C., Reid G. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett. Appl. Microbiol. 2009, 48:269-274.
44. Mego M., Majek J., Koncekova R., Ebringer L., Ciernikova S., Rauko P., Kovac M., Trupl J., Slezak P., Zajac V. Intramucosal bacteria in colon cancer and their elimination by probiotic strain Enterococcus faecium M-74 with organic selenium. Folia Microbiol. (Praha) 2005, 50:443-447.
45. Metchnikoff I.I. The Prolongation of Life: Optimistic Studies 2004, Springer Publishing Company, New York, NY, USA.
46. Metchnikoff I.I., Mitchell P.C. Nature of Man or Studies in Optimistic Philosophy 1910, Kessinger Publishing, Whitefish, MT, USA.
47. Michail S., Abernathy F. Lactobacillus plantarum reduces the in vitrosecretory response of intestinal epithelial cells to enteropatho-genic Escherichia coli infection. J. Pediatr. Gastroenterol. Nutr. 2002, 35(3):350-355.
48. Nguyen T.D., Kang J.H., Lee M.S. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int. J. Food Microbiol. 2007, 113:358-361.
49. Niers L., Martin R., Rijkers G., Sengers F., Timmerman H., van Uden N., Smidt H., Kimpen J., Hoekstra M. The effects of selected Probiotic strains on the development of eczema (the P and A study). Allergy 2009, 64:1349-1358.
50. O'Sullivan M.G., Thornton G., O'Sullivan G.C., Collins J.K. Probiotic bacteria: myth or reality. Trends Food Sci. Technol. 1992, 3:309-314.
51. Parker R.B. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health 1974, 29:4-8.
52. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., Klaenhammer T.R. New scientific paradigms for Probiotics and prebiotics. J. Clin. Gastroenterol. 2003, 37:105-118.
53. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., Yolken R.H. Feeding of Bifidobacterium bifidum and Streptococcus thermophilusto infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994, 344:1046-1049.
54. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Fondén R., Saxelin M., Collins K., Mogensen G., Birkeland S.E., Mattila-Sandholm T. Demonstration of safety of Probiotics - a review. Int. J. Food Micro biol. 1998, 44:93-106.
55. Silva M., Jacobs N.V., Deneke C., Gorbach S.L. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 1987, 31:1231-1233.
56. Soh S.E., Aw M., Gerez I., Chong Y.S., Rauff M., Ng Y.P., Wong H.B., Pai N., Lee B.W., Shek L.P. Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1year. Clin. Exp. Allergy 2009, 39:571-578.
57. Strowski M.Z., Wiedenmann B. Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases. Gut 2009, 58:1044-1045.
58. Thirabunyanon M., Boonprasom P., Niamsup P. Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol. Lett. 2009, 31:571-576.
59. Tomas M.S., Claudia Oter M., Ocana V., Elena Nader-Macias M. Production of antimicrobial substances by lactic acid bacteria I: determination of hydrogen peroxide. Methods Mol. Biol. 2004, 268:337-346.
60. Ukena S.N., Westendorf A.M., Hansen W., Rohde M., Geffers R., Coldewey S., Suerbaum S., Buer J., Gunzer F. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med. Genet. 2005, 6:43.
61. van der Aa L.B., Sprikkelman A.B., van Aalderen W.M. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization. Clin. Exp. Allergy 2008, 38:1698. author reply 1698-9.
62. Vanderhoof J.A. Probiotics and intestinal inflammatory disorders in infants and children. J. Pediatr. Gastroenterol. Nutr. 2000, 30:S34-S38.
63. Viljanen M., Kuitunen M., Haahtela T., Juntunen-Backman K., Korpela R., Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol. 2005, 16:65-71.
64. Viljanen M., Pohjavuori E., Haahtela T., Korpela R., Kuitunen M., Sarnesto A., Vaarala O., Savilahti E. Induction of inflammation as a possible mechanism of Probiotic effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol. 2005, 115:1254-1259.
65. White J.S., Hoper M., Parks R.W., Clements W.D., Diamond T., Bengmark S. The probiotic bacterium Lactobacillus plantarum species 299 reduces intestinal permeability in experimental biliary obstruction. Lett. Appl. Microbiol. 2006, 42:19-23.
66. Whorwell P.J., Altringer L., Morel J., Bond Y., Charbonneau D., O'Mahony L., Kiely B., Shanahan F., Quigley E.M. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol. 2006, 101:1581-1590.
67. Yamada T., Nagata S., Kondo S., Bian L., Wang C., Asahara T., Ohta T., Nomoto K., Yamashiro Y. Effect of continuous probiotic fermented milk intake containing Lactobacillus casei strain Shirota on fever in mass infectious gastroenteritis rest home outbreak. Kansenshogaku Zasshi 2009, 83:31-35.
68. Zhou J.S., Pillidge C.J., Gopal P.K., Gill H.S. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Int. J. Food Microbiol. 2005, 98:211-217.